Anygen Co., Ltd.

KOSDAQ:A196300 주식 보고서

시가총액: ₩83.6b

Anygen 과거 수익 실적

과거 기준 확인 0/6

Anygen's earnings have been declining at an average annual rate of -6.8%, while the Biotechs industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 0.05% per year.

주요 정보

-6.8%

수익 성장률

-1.9%

EPS 성장률

Biotechs 산업 성장11.7%
매출 성장률-0.05%
자기자본 수익률-92.7%
순이익-136.9%
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Would Anygen (KOSDAQ:196300) Be Better Off With Less Debt?

Aug 29
Would Anygen (KOSDAQ:196300) Be Better Off With Less Debt?

Does Anygen's (KOSDAQ:196300) Share Price Gain of 86% Match Its Business Performance?

Mar 11
Does Anygen's (KOSDAQ:196300) Share Price Gain of 86% Match Its Business Performance?

Is Anygen (KOSDAQ:196300) Using Too Much Debt?

Jan 17
Is Anygen (KOSDAQ:196300) Using Too Much Debt?

Should Anygen (KOSDAQ:196300) Be Disappointed With Their 64% Profit?

Nov 24
Should Anygen (KOSDAQ:196300) Be Disappointed With Their 64% Profit?

수익 및 비용 분석

Anygen 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

KOSDAQ:A196300 수익, 비용 및 수입 (KRW Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 246,004-8,2211,9621,178
31 Mar 246,423-9,2092,1701,402
31 Dec 235,611-9,0792,0591,494
30 Sep 236,217-7,8891,9691,514
30 Jun 236,292-8,5302,1491,614
31 Mar 236,700-6,1382,0141,709
31 Dec 228,662-6,2052,0472,099
30 Sep 2211,137-1,2401,9452,050
30 Jun 2211,367-4142,0451,995
31 Mar 2211,902-2,0382,0291,759
31 Dec 2110,267-1,6901,9331,240
30 Sep 217,488-3,3941,9621,213
30 Jun 218,228-3,3381,9811,105
31 Mar 218,475-2,1632,2631,133
31 Dec 208,516-2,4622,7731,150
30 Sep 208,614-4,6103,2051,172
30 Jun 208,210-5,1293,5811,268
31 Mar 206,831-6,1883,8191,289
31 Dec 196,277-6,6453,9801,367
30 Sep 195,987-8,4203,8051,289
30 Jun 195,328-8,4683,5011,267
31 Mar 194,622-8,4343,0991,341
31 Dec 184,114-7,1642,4171,072
30 Sep 183,533-3,2772,114967
30 Jun 183,854-1,8981,738665
31 Mar 184,463991,524171
31 Dec 174,5524481,464189
30 Sep 174,736-152,276161
30 Jun 174,502-6302,244221
31 Mar 174,362-1,3042,024411
31 Dec 164,177-1,6471,834361
30 Jun 163,994-2,794719542
31 Dec 153,722-2,574601768
31 Dec 143,677-36268968
31 Dec 134,00715365594

양질의 수익: A196300 is currently unprofitable.

이익 마진 증가: A196300 is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: A196300 is unprofitable, and losses have increased over the past 5 years at a rate of 6.8% per year.

성장 가속화: Unable to compare A196300's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: A196300 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (6.1%).


자기자본 수익률

높은 ROE: A196300 has a negative Return on Equity (-92.7%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기